Web-based tailored information and support for patients with a neuroendocrine tumor: a randomized pilot study.
Completed
- Conditions
- Psychosociale problemenneuroendocrine tumor/distressquality of life10027656
- Registration Number
- NL-OMON40475
- Lead Sponsor
- niversitair Medisch Centrum Groningen
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 20
Inclusion Criteria
- Adult NET patients (aged >= 18 years of age) with any tumor site and disease stage.
- Ability to comprehend Dutch (both reading and writing).
- Informed consent provided.
Exclusion Criteria
- Estimated life expectancy less than 3 months.
- Patients with a second primary tumor for which active follow-up or treatment.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The primary endpoint is to detect an improvement in patients* perception and<br /><br>satisfaction of received information after having received web-based tailored<br /><br>information and support. We will use the EORTC QLQ-INFO25 questionnaire to<br /><br>evaluate the primary endpoint.</p><br>
- Secondary Outcome Measures
Name Time Method <p>- To test whether patients experience less distress after having received<br /><br>web-based tailored information and support system.<br /><br>- To test whether patients experience a higher quality of life after receiving<br /><br>web-based tailored information and support system.<br /><br>- To examine whether a web-based tailored information and support system<br /><br>enhances empowerment within the meaning of being better informed, feeling more<br /><br>confident in the relationship with their physician, improved acceptance of the<br /><br>illness, feeling more confident about the treatment and increased optimism and<br /><br>control over the future.4.<br /><br>- To assess patients* opinion and satisfaction with the web-based system.</p><br>